Hernández MSE, Cornejo BRH, Magaña ZL, García DL

Language: Spanish
References: 15
Page: 119-122
PDF size: 138.75 Kb.

ABSTRACT

Introduction: Antiphospholipid syndrome is part of a wide range of autoimmune diseases like systemic lupus erythematosus. As part of retina features of the disease we may find signs of oclusive vasculitis with tractional retinal detachment.
Case report: A 30 year old female patient with ischemic retinopathy and tractional retinal detachment, total aortic obstruction was documented with renal failure, positive lupic anticoagulant and positive anticardiolipine antibodies. Antiphospholipid syndrome diagnosis was made.
Discussion: Although the most common cause of ischemic retinopathy is diabetes, there are other diseases that must be ruled out, mainly in young patients, such as antiphospholipid syndrome.

REFERENCES

1. Zhuravlev GI, Rodshte [Characteristics of clinical course and immunology of systemic lupus erythematosus (SLE) in males]. Sov Med 1974; 10(7): 99-103.

2. Coroi M, Bontas E, Defranceschi M, Bartos D, Dorobantu M. Ocular manifestations of antiphospholipid (Hughes)’ syndrome- minor features? Oftalmologia 2007; 51(3):16-22.

3. Avetisov SE, Smirnova TV, Kozlovskaia NL, Kiseleva TN, Eliseeva EG y cols. Vasoocclusive retinopathy in a patient with primary antiphospholipid syndrome. Vestn Oftalmol 2007; 123(3):46-8.

4. Carrero JL, Sanjurjo FJ. Bilateral cilioretinal artery occlusion in antiphospholipid syndrome. Retina 2006; 26(1):104-6.

5. Ermakova NA, Alekberova ZS, Reshetniak TM y cols. Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome. Vestn Oftalmol 2005; 121(5):31-6.

6. Au A, O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol 2004; 32(1):87-100.

7. Monshizadeh R, Werner M, Richards H, Tabandeh H, Bhatti MT. Vitreous hemorrhage as the presenting sign of antiphospholipid syndrome. Can J Ophthalmol 2003; 38(7):607-9.

8. Levy J, Baumgarten A, Rosenthal G, Rabinowitz R, Lifshitz T. Consecutive central retinal artery and vein occlusions in primary antiphospholipid syndrome. Retina 2002; 22(6):784-6.

9. Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol 2001; 131(4):451-6.

10. Demirci FY, Küçükkaya R, Akarçay K, Kir N, Atamer T, Demirci H, Ongör E. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS. Int Ophthalmol. 1998; 22(6):323-9. Erratum in: Int Ophthalmol 1999; 23(3):181.

11. Leo-Kottler B, Klein R, Berg PA, Zrenner E. Ocular symptoms in association with antiphospholipid antibodies. Graefes Arch Clin Exp Ophthalmol 1998; 236(9):658-68.

12. Wiechens B, Schröder JO, Pötzsch B, Rochels R. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 1997; 123(6):848-50.

13. Smith JR, Chng H, Chee S. Primary antiphospholipid syndrome masquerading as diabetic retinopathy. Jpn J Ophthalmol 2001; 45(1):105-8.

14. Kiyosawa M, Baba T. Ophthalmological findings in patients with Takayasu disease. Int J Cardiol 1998; 66 (Supl 1): S141-7; discusión S149.

15. Kent D, Hickey-Dwyer M, Clark D. Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease. Eye 2000; 14( Pt 3A):313-7.